Biocat

What Biocat does

Biocat (legal name: Biocat, la Fundació BioRegió de Catalunya) is a public-private foundation established in 2006 at the initiative of the Government of Catalonia and Barcelona City Council, headquartered at the Parc Científic de Barcelona. It functions as the official cluster coordinator for Catalonia's life sciences and healthcare innovation ecosystem — known as the BioRegion of Catalonia — rather than as a product company. Biocat does not develop proprietary technology products; instead, its core activity is orchestrating innovation across the ecosystem through a portfolio of interconnected programs and digital platforms, including acceleration programs (CRAASH Barcelona, ATMP Catalyst), training programs (d·HEALTH Barcelona), the Health Investment Portal connecting startups with investors, the PASS program for healthcare system adoption, the ATMP Catalonia advanced therapies hub, and the European PRECISEU project on personalized medicine. It also publishes the annual BioRegion Report, the authoritative intelligence source for the sector.

Biocat serves five primary stakeholder segments: startups and spin-offs in biotech, medtech, digital health, and advanced therapies; research institutions and universities; domestic and international investors and corporate venture arms (e.g., Ysios, Asabys, Novartis, Roche, Sanofi, Werfen); the Catalan Health System (SISCAT) through CatSalut, AQuAS, and the Ministry of Health; and large corporates seeking partnership and licensing opportunities. All core programs and services are provided free of charge to participants, with operations funded through institutional grants, public funding programs, and trustee support. Governance is shared: the Board of Trustees includes ministers from the Government of Catalonia alongside representatives from pharmaceutical companies, industry associations (Farmaindustria, Fenin Catalunya, Catalonia.Health), research institutions, and venture capital firms, with the President of the Government of Catalonia serving as Chairman.

The organization has approximately 11–50 employees led by CEO Robert Fabregat and a director team covering strategy, marketing, finance, acceleration, and scale-up. Its reach extends across 1,650 companies, 94 research institutions, 464 active startups, and 80+ investment firms operating in the BioRegion, with the broader sector representing 7.6% of Catalonia's GDP, €48.691 billion in turnover, and €9.165 billion in healthcare exports (45.7% of Spain's national total).

Name

Biocat

Legal name

Biocat, la Fundació BioRegió de Catalunya

Website

https://biocat.cat

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Biocat is the public-private foundation coordinating Catalonia's life sciences and healthcare innovation ecosystem, serving startups, research institutions, investors, corporates, and the Catalan Health System through acceleration programs, investment matching platforms, and adoption programs.

Ownership category

akta.pro rank

Headquarters

HQ city

Barcelona

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Institutional / Public Funding: Biocat operates as a public-private foundation established in 2006 at the initiative of the Government of Catalonia and Barcelona City Council. It is funded through institutional grants, public funding programs, and membership/support from private-sector trustees. The foundation does not charge for its core programs and services.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

Biocat is a public-private foundation that coordinates the life sciences and healthcare innovation ecosystem of Catalonia by running acceleration programs (CRAASH Barcelona, d·HEALTH Barcelona, ATMP Catalyst), investment matchmaking via the Health Investment Portal, healthcare-system adoption programs (PASS, INNOPASS), the ATMP Catalonia advanced-therapies hub, European project coordination (PRECISEU), and ecosystem intelligence (BioRegion of Catalonia Report). All programs and services are offered free of charge to entrepreneurs, researchers, investors, corporates, and the Catalan Health System.

Product overview

Biocat functions as a public-private foundation that coordinates and accelerates the life sciences and healthcare innovation ecosystem in Catalonia, rather than as a single product company. Its offering consists of multiple interconnected programs and platforms: acceleration programs (CRAASH Barcelona, d·HEALTH Barcelona, ATMP Catalyst) that support entrepreneurs and researchers; the Health Investment Portal connecting startups with investors; the ATMP Catalonia hub for advanced therapies; and the PASS (Catalan Health System Innovation Access Program) comprising an Innovation Platform, Tools and Programs Navigator, and Support Unit to facilitate healthcare innovation adoption. Additionally, Biocat coordinates European projects like PRECISEU and publishes the BioRegion of Catalonia Report as the official intelligence source for the ecosystem. The programs and platforms work together to support the full innovation lifecycle from research to market adoption and investment.

Differentiator

Problem solved

Functional benefit

Brands

• ATMP Catalonia: The Advanced Therapies Hub of Catalonia, coordinated by Biocat, which drives research, manufacturing and development of advanced and emerging therapies to position Catalonia as a global benchmark hub.
• PASS (Catalan Health System Innovation Access Program)
• CRAASH Barcelona
• d·HEALTH Barcelona

Products and services

• CRAASH Barcelona A three-month acceleration program (currently in its 9th edition) that validates and brings to market innovations in medical devices, diagnostics, and digital health. Targeted at research teams and entrepreneurs established in or linked to Catalonia with high-potential projects.
• d·HEALTH Barcelona A training program (currently in its 11th edition) that provides tools to learn how to innovate and develop a business model from unmet clinical needs. Aimed at students, researchers and professionals seeking to build careers in healthcare innovation, technology transfer or consulting.
• Health Investment Portal An online portal connecting academic projects and startups from across Catalonia that are seeking investment, licensing or co-development agreements with investors, corporates and technology transfer offices. Open to investors, corporates, TTOs and startups globally.
• The Investment Readiness Series A program that facilitates meetings between research project managers and investors, targeting companies and research entities with projects ready to receive investment.
• ATMP Catalonia (Advanced Therapies Hub of Catalonia) A coordinated hub of companies and entities working on advanced and emerging therapies (ATMPs) to position Catalonia as a global reference hub. Facilitates technology transfer, knowledge sharing, collaboration among R&D groups, and promotion of public-private partnerships.
• ATMP Catalyst A structured three-year acceleration program supporting early-stage projects and startups in advanced therapies to advance science and empower startups in transforming healthcare.
• INNOPASS A semi-annual open call selecting innovations developed in the BioRegion of Catalonia that contribute to healthcare system transformation. Awards an 'Innovation Passport' to solutions with high maturity and strong clinical, organizational, social or environmental impact potential, and provides one year of personalized support.
• PASS (Catalan Health System Innovation Access Program) A comprehensive program that coordinates innovation access to the Catalan Health System. Includes an innovation platform, a tools and programs navigator, and a support unit that runs cohorts of selected startups with personalized scientific, technological and strategic guidance.
• Innovation Platform (Health Innovation Communities) A directory-format platform featuring innovations candidates to access the Catalan Health System, facilitating interaction and connection among healthcare system stakeholders, solution providers and assessment bodies.
• Tools and Programs Navigator A comprehensive catalog of resources, programs and opportunities available to the innovation community in Catalonia, including acceleration programs, funding opportunities, validation services and regulatory support.
• PRECISEU A European project coordinated by Biocat that strengthens collaboration between health innovation ecosystems and actors across Europe to share knowledge, scale solutions and drive transformation toward personalized and digital health models.
• BioRegion of Catalonia Report The most comprehensive analysis of assets, achievements and trends in the life sciences and healthcare sector in Catalonia, published annually since 2009. Provides official indicators on the evolution of the healthcare innovation ecosystem.
• Catalonia Life Sciences Database A comprehensive database of the BioRegion of Catalonia providing strategic information about companies, research institutions and stakeholders in the life sciences and healthcare ecosystem.
• Health Innovation Communities An online platform facilitating connection and collaboration among health innovation stakeholders in the BioRegion of Catalonia, hosting the PASS Support Unit and community interactions.

Quantifiable outcome

• €517 million in startup and scaleup investment raised in 2025, a historic record (+43% vs. 2024)
• +3 more outcomes

Named customers10 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

14 partnerships are on record, tiered supporting and core.

• ACCIÓ (Government of Catalonia)supportingOthers · 1 January 2025ACCIÓ is the agency for business competitiveness of the Government of Catalonia that supports the internationalization of companies. Biocat collaborates with ACCIÓ as an agent for supporting internationalization of the BioRegion ecosystem.
• Catalan Ministry of Health (Departament de Salut)coreOthers · 1 January 2025Co-leads the PASS (Catalan Health System Innovation Access Program) with CatSalut, AQuAS, and Biocat. Charged Biocat with coordinating the expert subcommittee that drafted the action plan to streamline innovation adoption in the healthcare system.
• Servei Català de la Salut (CatSalut)coreOthers · 1 January 2025CatSalut is working on defining and specifying processes for innovation entry into SISCAT, including the new Programme for the Harmonised Adoption of Innovation in Healthcare (PAHISA). Co-leads PASS with Biocat.
• Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)coreOthers · 1 January 2025AQuAS is working on evaluation of health technologies and self-assessment tools to guide innovators in demonstrating value prior to adoption. Co-leads PASS with Biocat, CatSalut, and the Departament de Salut.
• Catalonia.BioHealth (Catalonia.Health)supportingOthers · 1 January 2025An association representing healthcare and life sciences companies in Catalonia. Represented on Biocat's Board of Trustees, contributing industry perspective to the foundation's governance.
• FarmaindustriasupportingOthers · 1 January 2025The Spanish pharmaceutical industry association, represented on Biocat's Board of Trustees with multiple members including representatives from Amgen, AstraZeneca, Almirall, Laboratorios Ern, and Sanofi-Aventis.
• Fenin CatalunyasupportingOthers · 1 January 2025The Spanish federation of healthcare technology companies in Catalonia, represented on Biocat's Board of Trustees through representatives from HARTMANN Group and Avinent Group.
• PRECISEU (EU-funded project)coreStrategic or Co-development Partner · 1 January 2025PRECISEU is a European project coordinated by Biocat that strengthens collaboration between health innovation ecosystems and actors across Europe to share knowledge, scale solutions, and drive transformation of health systems toward more personalized and digital models. It connects ecosystems and promotes adoption of personalized medicine.
• Horizon Europe / Horizon 2020coreStrategic or Co-development Partner · 1 January 2025Between 2014 and 2023, over 200 organizations and companies in the BioRegion participated in 1,198 collaborative research and innovation projects under Horizon 2020 and Horizon Europe programs, with collaborations in 88 countries and mobilizing €3.77 billion in resources.
• Xarxa de Parcs Científics i Tecnològics de CatalunyasupportingStrategic or Co-development Partner · 1 January 2025The network of science and technology parks of Catalonia, represented on Biocat's Board of Trustees through the Director of Parc Científic de Barcelona.
• Associació Catalana d'Entitats de Recerca (ACER)supportingStrategic or Co-development Partner · 1 January 2025Represented on Biocat's Board of Trustees through the Director of the Institute for Research in Biomedicine (IRB Barcelona).
• AstraZenecacoreOthers · 1 January 2025AstraZeneca made a strategic commitment to the BioRegion including a major investment hub. Between 2021 and 2025, FDI totalled €2.382 billion with AstraZeneca's commitment playing a key role, generating 5,567 new jobs.
• Government of CataloniacoreOthers · 1 January 2006Co-founding partner of Biocat along with Barcelona City Council. Represents the public sector stakeholders in the foundation's governance, including multiple ministries (Health, Economy, Research, Business, Agriculture) on the Board of Trustees.
• Barcelona City CouncilcoreOthers · 1 January 2006Co-founding partner of Biocat along with the Government of Catalonia, establishing Biocat as a public-private foundation since 2006.

Scale indicators14 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• EIT Health: EIT Health is a European-wide public-private partnership (Knowledge and Innovation Community) under Horizon Europe that coordinates health innovation across Europe. Broader in geographic scope than Biocat, with overlap on acceleration programs and healthcare-system transformation objectives pursued by Biocat via PRECISEU.

Direct peers

• Medicon Valley Alliance: Medicon Valley Alliance is the life sciences cluster organization bridging Denmark and Sweden, focused on the greater Copenhagen-Skåne region. It is a direct functional peer to Biocat, running networking, investment-matching, and policy advocacy for life sciences stakeholders.
• BIOCOM: BIOCOM is the California-based life sciences association supporting San Diego and California life sciences companies through networking, capital access, and public policy advocacy, similar to Biocat's mandate for Catalonia.
• Lyonbiopôle: Lyonbiopôle is the French competitive cluster dedicated to health and life sciences in the Auvergne-Rhône-Alpes region. Comparable to Biocat as a regional innovation cluster coordinating industry, research, and healthcare system stakeholders.
• BioAlps: BioAlps is the life sciences cluster organization for Western Switzerland, based in Geneva. It performs an ecosystem coordination role analogous to Biocat, including networking, acceleration support, and promotion of regional life sciences activity on an international stage.
• One Nucleus: One Nucleus is the life sciences and healthcare cluster organization for the Cambridge-London corridor in the UK. It operates similarly to Biocat as a not-for-profit membership body driving deal flow, internationalization, and talent development for life sciences companies.
• flanders.health (formerly FlandersBio): flanders.health is the Flemish life sciences cluster organization coordinating biotech, medtech, and pharma stakeholders in Belgium. Comparable to Biocat in operating model, member base, and emphasis on accelerating innovation access to healthcare systems.
• Clust-ER Health (Emilia-Romagna): Clust-ER Health is the health cluster of the Emilia-Romagna region in Italy, part of the regional innovation ecosystem coordination model. Functions as a peer to Biocat in coordinating regional life sciences stakeholders and supporting industry-academia collaboration within a public-private framework.
• Massachusetts Biotechnology Council (MassBio): MassBio is the trade association and innovation cluster organization for Massachusetts' life sciences industry, coordinating industry, academia, and government. It is the closest international analogue to Biocat in scope, governance, and program offering, though it operates at significantly larger scale in a US context.
• BioM (Bavaria): BioM is the cluster management organization for the biotechnology sector in Bavaria, Germany. Like Biocat, it coordinates research-to-market activities, runs acceleration programs, and connects startups with pharma and investors, making it a direct regional cluster peer within the European life sciences ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks4 records

Key highlights7 records

Customer concentration

• Xx.com/biocat_en
• Facebookfacebook.com/biocat.bioregiodecatalunya
• LinkedInlinkedin.com/company/biocat-bioregion-of-catalonia

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biocat